PDS Biotechnology
PDSB
PDSB
37 hedge funds and large institutions have $8.01M invested in PDS Biotechnology in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Holders
37
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$204K | |
2 | +$25.1K | |
3 | +$21.1K | |
4 |
BFM
Boothbay Fund Management
New York
|
+$16K |
5 |
Renaissance Technologies
New York
|
+$13.8K |
Top Sellers
1 | -$364K | |
2 | -$167K | |
3 | -$103K | |
4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$99K |
5 |
D.E. Shaw & Co
New York
|
-$79.5K |